Shuyu Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shuyu Zhu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Zhigang Xie
Dept. of Oral Implantology, the Affiliated Stomatology Hospital of Kunming Medical University, Kunming, China
2 shared publications Jing Zhou
Kunming Medical University School of Stomatology and Affiliated Stomatology Hospital Kunming Yunnan Province China
1 shared publication- Jing Zhou
Department of Stomatology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, Yunnan, China.
1 shared publication Peng Ling
Dept. of Oral Implantology, the Affiliated Stomatology Hospital of Kunming Medical University, Kunming, China; Yunnan Key Laboratory of Stomatology, School of Stomatology, Kunming Medical University, Kunming, China
1 shared publication- Rongkun Chen
Yunnan Key Laboratory of Stomatology, School of Stomatology, Kunming Medical University, Kunming, China; Dept. of Periodontology, the Affiliated Stomatology Hospital of Kunming Medical University, Kunming, China
1 shared publication Shu Zhang
Dept. of Oral Implantology, the Affiliated Stomatology Hospital of Kunming Medical University, Kunming, China
1 shared publication
Latest Publications
- Open Access
- 4 September 2025
- Published by Elsevier in International Dental Journal
- Vol. 75 (6) , 103853
Demineralized Dentin Matrix Promotes Bone Regeneration Through IDO1-Mediated Th17/Treg Cell Balance Modulation
- 4 September 2025
- Published by Elsevier in International Dental Journal
- Vol. 75 (6) , 103853
Open AccessDemineralized Dentin Matrix Promotes Bone Regeneration Through IDO1-Mediated Th17/Treg Cell Balance Modulation
- Open Access
- 12 September 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (9) , e70011
The balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering
Background: Bone regeneration is a well‐regulated dynamic process, of which the prominent role of the immune system on bone homeostasis is more and more revealed by recent research. Before fully activation of the bone remodeling cells, the immune system needs to clean up the microenvironment in facilitating the bone repair initiation. Furthermore, this microenvironment must be maintained properly by various mechanisms over the entire bone regeneration process.Objective: This review aims to summarize the role of the T‐helper 17/Regulatory T cell (Th17/Treg) balance in bone cell remodeling and discuss the relevant progress in bone tissue engineering.Results: The role of the immune response in the early stages of bone regeneration is crucial, especially the impact of the Th17/Treg balance on osteoclasts, mesenchymal stem cells (MSCs), and osteoblasts activity. By virtue of these knowledge advancements, innovative approaches in bone tissue engineering, such as nano‐structures, hydrogel, and exosomes, are designed to influence the Th17/Treg balance and thereby augment bone repair and regeneration.Conclusion: Targeting the Th17/Treg balance is a promising innovative strategy for developing new treatments to enhance bone regeneration, thus offering potential breakthroughs in bone injury clinics.
- 12 September 2024
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 12 (9) , e70011
Open AccessThe balance between helper T 17 and regulatory T cells in osteoimmunology and relevant research progress on bone tissue engineering
Background: Bone regeneration is a well‐regulated dynamic process, of which the prominent role of the immune system on bone homeostasis is more and more revealed by recent research. Before fully activation of the bone remodeling cells, the immune system needs to clean up the microenvironment in facilitating the bone repair initiation. Furthermore, this microenvironment must be maintained properly by various mechanisms over the entire bone regeneration process.Objective: This review aims to summarize the role of the T‐helper 17/Regulatory T cell (Th17/Treg) balance in bone cell remodeling and discuss the relevant progress in bone tissue engineering.Results: The role of the immune response in the early stages of bone regeneration is crucial, especially the impact of the Th17/Treg balance on osteoclasts, mesenchymal stem cells (MSCs), and osteoblasts activity. By virtue of these knowledge advancements, innovative approaches in bone tissue engineering, such as nano‐structures, hydrogel, and exosomes, are designed to influence the Th17/Treg balance and thereby augment bone repair and regeneration.Conclusion: Targeting the Th17/Treg balance is a promising innovative strategy for developing new treatments to enhance bone regeneration, thus offering potential breakthroughs in bone injury clinics.